11:45 AM EST - Fennec Pharmaceuticals Inc. : reported its financial results for the third quarter ended September 30. Loss from operations totaled $338,000 U.S., compared to $619,000 U.S. in the prior-year quarter. Fennec Pharmaceuticals Inc.
shares T.FRX are trading down $0.14 at $1.72.
